Melanoma Drugs in Development by Stages, Target, MoA, RoA, Molecule Type and Key Players, 2022 Update
Powered by 
All the vital news, analysis, and commentary curated by our industry experts.
Melanomas usually occur on the skin but can arise in other locations where neural crest cells migrate, such as in the gastrointestinal tract or brain. It is more common in women than in men. The Melanoma pipeline market research report provides comprehensive information on the therapeutics under development for Melanoma, complete with analysis by stage of development, drug target, mechanism of action (MoA), route of administration (RoA), and molecule type. The report also covers the descriptive pharmacological action of the therapeutics, its complete research and development history, and the latest news and press releases. Additionally, the report provides an overview of key players involved in therapeutic development for Melanoma and features dormant and discontinued projects.
Melanoma Pipeline Products Market Segmentation by Targets
The key targets in the Melanoma pipeline products market are Programmed Cell Death Protein 1, Cytotoxic T Lymphocyte Protein 4, Programmed Cell Death 1 Ligand 1, Serine/Threonine Protein Kinase B Raf, Lymphocyte Activation Gene 3 Protein, Dual Specificity Mitogen Activated Protein Kinase Kinase 1, Tumor Necrosis Factor Receptor Superfamily Member 9, Vascular Endothelial Growth Factor Receptor 2, Tumor Necrosis Factor Receptor Superfamily Member 5, and CD3, among others. Programmed Cell Death Protein 1 is the leading target in the pipeline.
Melanoma Pipeline Products Market Analysis by Targets
For more target insights into the Melanoma pipeline products market, download a free report sample
Melanoma Pipeline Products Market Segmentation by Mechanisms of Action
The key mechanisms of action in the Melanoma pipeline products market are Programmed Cell Death Protein 1 Antagonist, Programmed Cell Death 1 Ligand 1 Inhibitor, Cytotoxic T Lymphocyte Protein 4 Antagonist, Serine/Threonine Protein Kinase B Raf Inhibitor, Lymphocyte Activation Gene 3 Protein Inhibitor, Dual Specificity Mitogen Activated Protein Kinase Kinase 1 Inhibitor, Tumor Necrosis Factor Receptor Superfamily Member 9 Agonist, Vascular Endothelial Growth Factor Receptor 2 Inhibitor, Tumor Necrosis Factor Receptor Superfamily Member 5 Agonist, and CD3 Agonist, among others. Programmed Cell Death Protein 1 Antagonist is the leading MoA in the pipeline market.
Melanoma Pipeline Products Market Analysis by Mechanisms of Action
For more mechanisms of action insights into the Melanoma pipeline products market, download a free report sample
Melanoma Pipeline Products Market Segmentation by Routes of Administration
The key routes of administration in the Melanoma pipeline products market are intravenous, oral, intratumor, subcutaneous, parenteral, intravenous drip, intradermal, intramuscular, intraperitoneal, and intralesional, among others. Intravenous is the most preferred route for administration.
Melanoma Pipeline Products Market Analysis by Routes of Administration
For more routes of administration insights into the Melanoma pipeline products market, download a free report sample
Melanoma Pipeline Products Market Segmentation by Molecule Types
The key molecule types in the Melanoma pipeline products market are small molecule, monoclonal antibody, cell therapy, fusion protein, gene-modified cell therapy, oncolytic virus, subunit vaccine, biologic, and monoclonal antibody conjugated, among others. The leading molecule is small molecule.
Melanoma Pipeline Products Market Analysis by Molecule Types
For more molecule type insights into the Melanoma pipeline products market, download a free report sample
Melanoma Pipeline Products Market - Competitive Landscape
Some of the leading companies in the Melanoma pipeline products market are Bristol-Myers Squibb Co, F. Hoffmann-La Roche Ltd, Merck & Co Inc, Novartis AG, Pfizer Inc, AstraZeneca Plc, Regeneron Pharmaceuticals Inc, Boehringer Ingelheim International GmbH, Eisai Co Ltd, and Incyte Corp. Bristol-Myers Squibb Co is the leading company in the Melanoma pipeline products market.
Melanoma Pipeline Products Market Analysis by Companies
To know more about the leading players in the Melanoma pipeline products market, download a free report sample
Melanoma Pipeline Products Market Report Overview
| Key Targets | Programmed Cell Death Protein 1, Cytotoxic T Lymphocyte Protein 4, Programmed Cell Death 1 Ligand 1, Serine/Threonine Protein Kinase B Raf, Lymphocyte Activation Gene 3 Protein, Dual Specificity Mitogen Activated Protein Kinase Kinase 1, Tumor Necrosis Factor Receptor Superfamily Member 9, Vascular Endothelial Growth Factor Receptor 2, Tumor Necrosis Factor Receptor Superfamily Member 5, and CD3 |
| Key Mechanisms of Action | Programmed Cell Death Protein 1 Antagonist, Programmed Cell Death 1 Ligand 1 Inhibitor, Cytotoxic T Lymphocyte Protein 4 Antagonist, Serine/Threonine Protein Kinase B Raf Inhibitor, Lymphocyte Activation Gene 3 Protein Inhibitor, Dual Specificity Mitogen Activated Protein Kinase Kinase 1 Inhibitor, Tumor Necrosis Factor Receptor Superfamily Member 9 Agonist, Vascular Endothelial Growth Factor Receptor 2 Inhibitor, Tumor Necrosis Factor Receptor Superfamily Member 5 Agonist, and CD3 Agonist |
| Key Routes of Administration | Intravenous, Oral, Intratumor, Subcutaneous, Parenteral, Intravenous Drip, Intradermal, Intramuscular, Intraperitoneal, and Intralesional |
| Key Molecule Type | Small Molecule, Monoclonal Antibody, Cell Therapy, Fusion Protein, Gene-Modified Cell Therapy, Oncolytic Virus, Subunit Vaccine, Biologic, and Monoclonal Antibody Conjugated |
| Leading Companies | Bristol-Myers Squibb Co, F. Hoffmann-La Roche Ltd, Merck & Co Inc, Novartis AG, Pfizer Inc, AstraZeneca Plc, Regeneron Pharmaceuticals Inc, Boehringer Ingelheim International GmbH, Eisai Co Ltd, and Incyte Corp |
Scope
- The pipeline guide provides a snapshot of the global therapeutic landscape of Melanoma (Oncology).
- The pipeline guide reviews pipeline therapeutics for Melanoma (Oncology) by companies and universities/research institutes based on information derived from company and industry-specific sources.
- The pipeline guide covers pipeline products based on several stages of development ranging from pre-registration till discovery and undisclosed stages.
- The pipeline guide features descriptive drug profiles for the pipeline products which comprise, product description, descriptive licensing and collaboration details, R&D brief, MoA & other developmental activities.
- The pipeline guide reviews key companies involved in Melanoma (Oncology) therapeutics and enlists all their major and minor projects.
- The pipeline guide evaluates Melanoma (Oncology) therapeutics based on mechanism of action (MoA), drug target, route of administration (RoA), and molecule type.
- The pipeline guide encapsulates all the dormant and discontinued pipeline projects.
- The pipeline guide reviews the latest news related to pipeline therapeutics for Melanoma (Oncology)
Reasons to Buy
- Procure strategically important competitor information, analysis, and insights to formulate effective R&D strategies.
- Recognize emerging players with potentially strong product portfolios and create effective counter-strategies to gain competitive advantage.
- Find and recognize significant and varied types of therapeutics under development for Melanoma (Oncology).
- Classify potential new clients or partners in the target demographic.
- Develop tactical initiatives by understanding the focus areas of leading companies.
- Plan mergers and acquisitions meritoriously by identifying key players and their most promising pipeline therapeutics.
- Formulate corrective measures for pipeline projects by understanding the Melanoma (Oncology) pipeline depth and focus of Indication therapeutics.
- Develop and design in-licensing and out-licensing strategies by identifying prospective partners with the most attractive projects to enhance and expand business potential and scope.
- Adjust the therapeutic portfolio by recognizing discontinued projects and understand from the know-how what drove them from the pipeline.
4SC AG
7 Hills Pharma LLC
9 Meters Biopharma Inc
Aadi Bioscience Inc
Abbisko Cayman Limited
AbbVie Inc
Abcuro Inc
Abion Inc
Abivax SA
ABM Therapeutics Inc
AC Bioscience SA
Accendatech Co Ltd
Accuitis Pharmaceuticals Inc
Acepodia Inc
Achilles Therapeutics Plc
Actuate Therapeutics Inc
Actym Therapeutics Inc
Adagene Suzhou Ltd
Adaptimmune Therapeutics Plc
Adare Pharma Solutions
ADC Therapeutics SA
Adlai Nortye Biopharma Co Ltd
Advanced BioDesign
AdvanCell Isotopes Pty Ltd
Advenchen Laboratories LLC
Adze Biotechnology Inc
Aeglea BioTherapeutics Inc
Affichem SA
Agenus Inc
AI Therapeutics Inc
AIkido Pharma Inc
AIM ImmunoTech Inc
AIMM Therapeutics BV (Inactive)
AiVita Biomedical Inc
Akeso Inc
Alkermes Plc
Allergy Therapeutics Plc
Alligator Bioscience AB
AlphaMab Co Ltd
Alphamab Oncology
AlphaVax Inc
Alpine Immune Sciences Inc
ALS Biopharma LLC
Alyra Therapeutics Inc
Ambrx Biopharma Inc
Amgen Inc
Aminex Therapeutics Inc
Amitech Therapeutic Solutions Inc
Anaveon AG
Andes Biotechnologies
AnGes Inc
Anhorn Medicines Co Ltd
Ansun Biopharma Inc
AntiCancer Inc
APEIRON Biologics AG
Apexian Pharmaceuticals Inc
Apexigen Inc
Aphios Corp
APO-T BV
Apogenix AG
Apollomics Inc
Arcus Biosciences Inc
Ardan Pharma
Arovella Therapeutics Ltd
Ascendis Pharma AS
Ascentage Pharma Group International
Asher Biotherapeutics Inc
Astellas Pharma Inc
Astex Pharmaceuticals Inc
AstraZeneca Plc
Athenex Inc
Atreca Inc
aTyr Pharma Inc
Aulos Bioscience Inc
Aurigene Discovery Technologies Ltd
Autolus Therapeutics Plc
Avalia Immunotherapies Ltd
Avidin Biotechnology Ltd
Avotres Inc
Avstera Therapeutics Inc
Axter Therapeutics Ltd
B-Side Pharma Ltd
Bantam Pharmaceutical LLC
Barricade Therapeutics Corp
Bayer AG
BeiGene Ltd
Beijing Immunochina Pharmaceuticals Co Ltd
Beijing Mabworks Biotech Co Ltd
Beijing Neoantigen Biotechnology Co Ltd
Beijing Tricision Biotherapeutics Inc
Beijing Weiyuan Likang Biological Technology Co Ltd
BerGenBio ASA
Bessor Pharma LLC
Betta Pharmaceuticals Co Ltd
BeyondSpring Inc
Binjiang Pharma, Inc.
Bio-Cancer Treatment International Ltd
Bio-Thera Solutions Ltd
BioAtla Inc
Biocad
Biocytogen Pharmaceuticals (Beijing) Co Ltd
Biogazelle NV
Biohaven Pharmaceutical Holding Company Ltd
BioInvent International AB
BioLineRx Ltd
BioMed Valley Discoveries Inc
Biomica
BioNTech SE
Bioquark Inc
Biosion Inc
BioVaxys Technology Corp
Biovista Inc
Bioviz Technologies Pvt Ltd
BioXcel Therapeutics Inc
bioXXmed AG
BJ Bioscience Inc
Blueprint Medicines Corp
Boehringer Ingelheim International GmbH
Boston Pharmaceuticals Inc
Brenus Pharma SA
BriaCell Therapeutics Corp
BridgeBio Pharma Inc
Bristol-Myers Squibb Co
Bromodomain Pharmaceuticals Inc
Byondis BV
C4 Therapeutics Inc
Calidi Biotherapeutics Inc
Calithera Biosciences Inc
Can-Fite BioPharma Ltd
Cancure Ltd
Cantargia AB
Canthera Discovery
CanWell Pharma Inc
Catalym GmbH
CDR-Life Inc
Celdara Medical LLC
Celldex Therapeutics Inc
Cellestia Biotech AG
Cellid Co Ltd
Celprogen Inc
Centrymed Pharmaceutical Inc
Centurion BioPharma Corp
Checkpoint Therapeutics Inc
Chengdu Fanxi Biopharma Co Ltd
Chia Tai Tianqing Pharmaceutical Group Co Ltd
Chimeric Therapeutics Ltd
Chimerix Inc
Chineo Med Beijing Co Ltd
Chinook Therapeutics Inc
Chugai Pharmaceutical Co Ltd
Claradele Pharmaceuticals Inc
Cloaked Therapeutics LLC
CNBX Pharmaceuticals Inc
Codagenix Inc
Codiak BioSciences Inc
CohBar Inc
Compass Therapeutics Inc
Convalife
Corvus Pharmaceuticals Inc
CStone Pharmaceuticals Co Ltd
Cue Biopharma Inc
Cura Therapeutics LLC
Curebiotech Inc
CureLab Oncology Inc
Curevac NV
Curigin Co Ltd
Cynata Therapeutics Ltd
Cytodyn Inc
Cytovation AS
CyTuVax BV
CZ BioMed Corp
Daiichi Sankyo Co Ltd
Debiopharm International SA
Deciphera Pharmaceuticals Inc
Defence Therapeutics Inc
DEKK-TEC Inc
Delta TpX Inc
Delta-Fly Pharma Inc
Dicerna Pharmaceuticals Inc
DNAtrix Inc
Dracen Pharmaceuticals Inc
Duet Therapeutics Inc
Dyadic International Inc
Eden Biologics Inc
Eikonoklastes Therapeutics Inc
Eisai Co Ltd
Eli Lilly and Co
Elicera Therapeutics AB
Elicio Therapeutics Inc
Ella Therapeutics Ltd
Elpiscience Biopharma Ltd
Emcure Pharmaceuticals Ltd
Enara Bio Ltd
ENB Therapeutics LLC
Epigene Therapeutics Inc
EpimAb Biotherapeutics Inc
Epizyme Inc
Erasca Inc
Eternity Bioscience Inc
Eucure (Beijing) Biopharma Co Ltd
Eutilex Co Ltd
Evaxion Biotech ApS
Evotec SE
Exelixis Inc
F-star Therapeutics Inc
F. Hoffmann-La Roche Ltd
Faknostics LLC
Faron Pharmaceuticals Oy
Fate Therapeutics Inc
Flow Pharma Inc
Fochon Pharmaceutical Ltd
Forte Biosciences Inc
Fujian Haixi New Medicine Creation Co Ltd
Galderma SA
Galectin Therapeutics Inc
Galecto Inc
Gene Surgery
Genelux Corp
Genemedicine Ltd
Genentech USA Inc
Generium
Genexine Inc
Gennao Bio Inc
Genocea Biosciences Inc
GenoImmune Therapeutics Biotechnology Co Ltd
GigaGen Inc
Gilead Sciences Inc
GLG Pharma SA
GlycoNex Inc
Gmax Biopharm LLC
GNT Biotech and Medicals Corp
Gnubiotics Sciences SA
GO Therapeutics Inc
Gradalis Inc
GSK plc
Guangdong Zhongsheng Pharmaceutical Co Ltd
Guangzhou FineImmune Biotechnology Co Ltd
Guangzhou Sinogen Pharmaceutical Co Ltd
Guangzhou Yinming Biomedical Technology Co Ltd
HaimBio Ltd
Hangzhou Neoantigen Therapeutics Co Ltd
Hangzhou Zenshine Pharmaceuticals Co Ltd
Hanmi Pharmaceuticals Co Ltd
Harbin Gloria Pharmaceuticals Co Ltd
Harbour BioMed (Guangzhou) Co Ltd
HCW Biologics Inc
Hercules Pharmaceuticals BV
Hibercell Inc
HiFiBiO Therapeutics Inc
Highlight Therapeutics SL
HKND YB1 Pharmaceutical Ltd
Hookipa Pharma Inc
Horizon Therapeutics Plc
Huabo Biopharm (Shanghai) Co Ltd
Huahui Anjian (Beijing) Biotechnology Co Ltd
Hualan Biological Engineering Inc
Hummingbird Bioscience Pte Ltd
HylaPharm
I-Mab
Ideaya Biosciences Inc
ImCheck Therapeutics SAS
Immatics NV
IMMD Inc
Immodulon Therapeutics Ltd
Immune Modulatory Therapies LLC
ImmuneCyte Inc
Immuneering Corp
ImmuneOnco Biopharmaceuticals (Shanghai) Co Ltd
ImmuneSensor Therapeutics Inc
Immunetune BV
ImmuNext Inc
ImmunityBio Inc
Immunocore Holdings Plc
Immunome Inc
Immunophotonics Inc
Immunos Therapeutics AG
ImmunSYS Inc
Immutep Ltd
Immvira Co Ltd
Imugene Ltd
Incuron
Incyte Corp
Infinity Pharmaceuticals Inc
Ingenew Pharmaceuticals Inc
IngenoVax LLC
Inhibrx Inc
Inmune Bio Inc
Innate Pharma SA
InnoBioPharma LLC
Innovative Cellular Therapeutics Co Ltd
Innovent Biologics Inc
Innovimmune Biotherapeutics Inc
Inovio Pharmaceuticals Inc
Instil Bio Inc
IntelliStem Technologies Inc
Intensity Therapeutics Inc
InterK Peptide Therapeutics Ltd
InteRNA Technologies BV
InxMed (Beijing) Co Ltd
IO Biotech Inc
iOnctura SA
Iovance Biotherapeutics Inc
ISOThrive Inc
Istari Oncology Inc
ISU ABXIS Co Ltd
iTeos Therapeutics Inc
Jacobio Pharmaceuticals Group Co Ltd
Jiangsu Chia-tai Tianqing Pharmaceutical Co Ltd
Jiangsu Hengrui Medicine Co Ltd
Jiangsu Sinorda Biomedicine Co Ltd
Jina Pharmaceuticals Inc
Johnson & Johnson
Joint Biosciences Ltd
Jounce Therapeutics Inc
JS InnoPharm (Shanghai) Ltd
JSK Therapeutics Inc
JSR Life Sciences LLC
Jubilant Therapeutics Inc
Kadmon Holdings Inc
Kairos Pharma Ltd
Kartos Therapeutics Inc
Karus Therapeutics Ltd
Karyopharm Therapeutics Inc
Kazia Therapeutics Ltd
Kezar Life Sciences Inc
Kine Sciences
Kinnate Biopharma Inc
Kolon Life Science Inc
Komipharm International Co Ltd
Kringle Pharma Inc
KSQ Therapeutics Inc
Kymab Ltd
Laboratorio Pablo Cassara SRL
Latima SIA
Learmont Pharmaceuticals Inc
Leidos Health Holdings LLC
Lentigen Technology Inc
Lepu Biopharma Co Ltd
Lidds AB
Ligand Pharmaceuticals Inc
LintonPharm Co Ltd
Lipo-Immuno Tech LLC
Lixte Biotechnology Holdings Inc
Lokon Pharma AB
Luye Pharma Group Ltd
Lyell Immunopharma Inc
Lytix Biopharma AS
Lyvgen Biopharma Ltd
MaaT Pharma
Mabwell Shanghai Bioscience Co Ltd
MacroGenics Inc
MAIA Biotechnology Inc
MaxiVAX SA
MedGene Therapeutics Inc
MediaPharma SRL
Medicenna Therapeutics Corp
MediciNova Inc
MediGene AG
Mediolanum farmaceutici SpA
MedPacto Inc
Mekanistic Therapeutics LLC
Memgen Inc
Merck & Co Inc
Merck KGaA
Merus NV
Meryx Inc
METiS Therapeutics Inc
MGC Pharmaceuticals Ltd
Microbiotica Ltd
Millennium Pharmaceuticals Inc
Miltenyi Biomedicine GmbH
Mina Therapeutics Ltd
MiNK Therapeutics Inc
Mirati Therapeutics Inc
MiReven Pty Ltd
Moderna Inc
Molecular Partners AG
Molecular Templates Inc
Moleculin Biotech Inc
Molecure SA
Morphiex Biotherapeutics Inc
Morphogenesis Inc
Mosaic ImmunoEngineering Inc
Mountain Valley MD Holdings Inc
Multitude therapeutics Inc
MultiVir Inc
MyeloRx LLC
NA Vaccine Research Institute Co Ltd
Nanjing Aimeifei Biomedical Technology Co Ltd
Nanobiotix SA
NantBioScience Inc
Neonc Technologies Inc
NeoTX Therapeutics Ltd
NeuClone Pty Ltd
Neumedicines Inc
New Amsterdam Sciences Inc
NewG Lab Pharma Co Ltd
NewG Lab Pharma Inc
NEX-I Inc
NextCure Inc
NGM Biopharmaceuticals Inc
NH TherAguix SAS
NightHawk Biosciences Inc
Nimbus Therapeutics LLC
Ningbo Wenda Pharmaceutical Technology Co Ltd
NirogyOne Therapeutics Inc
Nouscom AG
Novartis AG
Nubiyota LLC
NuCana Plc
Nurix Therapeutics Inc
Nuvation Bio Inc
Nuvectis Pharma Inc
Nynex Therapeutics LLC
Obsidian Therapeutics Inc
Ocuphire Pharma Inc
Olatec Therapeutics LLC
OliPass Corporation
Omeros Corp
Ona Therapeutics SL
OncoC4 Inc
Oncology Research International Ltd
Oncolys BioPharma Inc
Onconova Therapeutics Inc
OncoResponse Inc
Oncorus Inc
OncoSec Medical Inc
OncoTartis Inc
Oncotelic Therapeutics Inc
Oncovir Inc
Oneness Biotech Co Ltd
OnKure Inc
Ono Pharmaceutical Co Ltd
Orano Med LLC
Orbis Health Solutions LLC
Orgenesis Inc
Orpheus Therapeutics Inc
Oryn Therapeutics
Otsuka Pharmaceutical Co Ltd
Oxcia AB
Oxford BioTherapeutics Ltd
Pacific Northwest Biotechnology LLC
Pact Pharma Inc
Palleon Pharmaceuticals Inc
Palm Therapeutics Inc
Pan Cancer T BV
Paranta Biosciences Ltd
Partner Therapeutics Inc
PCI Biotech Holding ASA
PDC Line Pharma SAS
PDS Biotechnology Corp
PepVax Inc
PersonGen BioTherapeutics (Suzhou) Co Ltd
Pfizer Inc
PharmaTher Holdings Ltd
Philogen SpA
Phio Pharmaceuticals Corp
Phoenix Life Sciences International Ltd
Phoenix Molecular Designs
PHusis Therapeutics Inc
PlantForm Corp
Plexxikon Inc
Plus Therapeutics Inc
POINT Biopharma Global Inc
PokeAcell
Polynoma LLC
Polyplus-Transfection SA
Portage Biotech Inc
Prelude Therapeutics Inc
Prestige BioPharma Ltd
Primevax Immuno Oncology Inc
PRISM Pharma Co Ltd
Processa Pharmaceuticals Inc
Promore Pharma AB
Propanc Biopharma Inc
Protheragen Inc
Provectus Biopharmaceuticals Inc
Puma Biotechnology Inc
Puretech Health Plc
Purple Biotech Ltd
PYC Therapeutics Ltd
QBiotics Group Ltd
Qilu Pharmaceutical Co Ltd
Qilu Puget Sound Biotherapeutics Corp
Qu Biologics Inc
Quadriga BioSciences Inc
R-Pharm
Race Oncology Ltd
Ranger Biotechnologies AS
Rapa Therapeutics LLC
Recombio SL
Regeneron Pharmaceuticals Inc
RemeGen Co Ltd
Repertoire Immune Medicines Inc
Replimune Ltd
Resonant Therapeutics Inc
RetroVirox Inc
Reven Holdings Inc
Revere Pharmaceuticals Inc
Rubicon Biotechnology Inc
Salarius Pharmaceuticals Inc
Salubris Biotherapeutics Inc
SANOCHEMIA Pharmazeutika GmbH
Sanofi
Sapience Therapeutics Inc
Sapphire Biotech Inc
Sareum Holdings Plc
Scancell Holdings Plc
Scholar Rock Inc
Seagen Inc
Secura Bio Inc
Seven and Eight Biopharmaceuticals Corp
Seven and Eight Biopharmaceuticals Inc
Shandong Taize Huikang Biomedical Co Ltd
Shandong Xinchuang Biological Technology Co Ltd
Shanghai Celgen Bio-Pharmaceutical Co Ltd
Shanghai De Novo Pharmatech Co Ltd
Shanghai Gencells Therapeutics Co Ltd
Shanghai Grit Biotechnology Inc
Shanghai Haihe Biopharma Co Ltd
Shanghai Henlius Biotech Inc
Shanghai Hycharm Inc
Shanghai Junshi Bioscience Co Ltd
Shanghai Yuansong Biotechnology Co Ltd
Shattuck Labs Inc
Shenogen Pharma Group Ltd
Shenzhen Chipscreen Biosciences Co Ltd
Shionogi & Co Ltd
Sichuan Huiyang Life Science and Technology Corp
Sillajen Biotherapeutics
Simcha Therapeutics Inc
Sino Biopharmaceutical Ltd
Sirnaomics Ltd
Sonnet BioTherapeutics Holdings Inc
Sonoval LLC
Sorrento Therapeutics Inc
SOTIO Biotech AS
SpringWorks Therapeutics Inc
Starwise Therapeutics LLC
STAT3 Therapeutics Inc
Statera Biopharma Inc
Stcube Inc
Stella Pharmaceuticals Pvt Ltd
Sumitomo Dainippon Pharma Oncology, Inc
Sumitomo Pharma Co Ltd
Suntec Medical (Taiwan) Inc
Susavion Biosciences Inc
SuviCa Inc
Suzhou BlueHorse Therapeutics Co Ltd
Suzhou Dingfu Target Biotechnology Co Ltd
Suzhou Everhealth Biomedical Co Ltd
Suzhou Maximum Bio-tech Co Ltd
Suzhou Neupharma Co Ltd
SynDevRx Inc
Syndivia SAS
SynOx Therapeutics Ltd
Synthekine Inc
Synthis Therapeutics Inc
Syntrix Pharmaceuticals
Systimmune Inc
T-Cure Bioscience Inc
Tactical Therapeutics Inc
Tactiva Therapeutics LLC
TAE Life Sciences LLC
Taiga Biotechnologies Inc
Tailored Therapeutics LLC
TaiRx Inc
Takara Bio Inc
Takeda Pharmaceutical Co Ltd
Takis Srl
Targazyme Inc
Targovax ASA
TCR Cure Biopharma Technology Co Ltd
TCRx Therapeutics Co Ltd
Telesis Therapeutics LLC
Teon Therapeutics Inc
Tetranov International Inc
Tevogen Bio Inc
Theratechnologies Inc
Theravectys SA
Tikcro Technologies Ltd
TILT Biotherapeutics Ltd
Timmune Biotech Inc
Tollbridge Therapeutics LLC
Toray Industries Inc
Trained Therapeutix Discovery Inc
Treadwell Therapeutics Inc
TREAT U SA
Treos Bio Ltd
TScan Therapeutics Inc
Turning Point Therapeutics Inc
Turnstone Biologics Inc
Tvardi Therapeutics Inc
TVAX Biomedical Inc
UBI Pharma Inc
UbiVac Inc
Ultimovacs AS
United Immunity Co Ltd
Vaccinex Inc
Vaccizone
Vacthera BioTech GmbH
Valo Therapeutics Oy
Vascular Biogenics Ltd
Vault Pharma Inc
Vaxess Technologies Inc
Vaxil Bio Therapeutics Ltd
Vaximm AG
Veana Therapeutics LLC
Vedanta Biosciences Inc
Verastem Inc
VerImmune Inc
Verseau Therapeutics Inc
Veru Inc
Vichem Chemie Research Ltd
Viewpoint Molecular Targeting LLC
Vincerx Pharma Inc
Virocure Inc
ViruCure Therapeutics Ltd
VM Discovery Inc
VREX Therapeutics Inc
Vyriad Inc
Werewolf Therapeutics Inc
Western Oncolytics Ltd (Inactive)
WindMIL Therapeutics Inc
WntResearch AB
Wugen Inc
Wuhan Binhui Biotechnology Co Ltd
Wuhan YZY Biopharma Co Ltd
X4 Pharmaceuticals Inc
Xbrane Biopharma AB
Xcovery Holding Co LLC
XEME BioPharma Inc
Xencor Inc
Xiangxue Life Sciences
Xilio Therapeutics Inc
Xynomic Pharmaceuticals Holdings Inc
Y-mAbs Therapeutics Inc
Yisheng Biopharma Co Ltd
Ymmunobio AG
Yooyoung Pharm Co Ltd
Yukin Therapeutics SAS
Zelluna Immunotherapy AS
Zenith Epigenetics Ltd
Zhejiang Teruisi Pharmaceutical Co Ltd
Zhejiang Yangshengtang Biotech Co Ltd
Zucero Therapeutics Ltd
Zylem Biosciences Inc
Table of Contents
Frequently asked questions
-
What are the key targets in the Melanoma pipeline products market?
The key targets in the Melanoma pipeline products market are Programmed Cell Death Protein 1, Cytotoxic T Lymphocyte Protein 4, Programmed Cell Death 1 Ligand 1, Serine/Threonine Protein Kinase B Raf, Lymphocyte Activation Gene 3 Protein, Dual Specificity Mitogen Activated Protein Kinase Kinase 1, Tumor Necrosis Factor Receptor Superfamily Member 9, Vascular Endothelial Growth Factor Receptor 2, Tumor Necrosis Factor Receptor Superfamily Member 5, and CD3, among others.
-
What are the key mechanisms of action in the Melanoma pipeline products market?
The key mechanisms of action in the Melanoma pipeline products market are Programmed Cell Death Protein 1 Antagonist, Programmed Cell Death 1 Ligand 1 Inhibitor, Cytotoxic T Lymphocyte Protein 4 Antagonist, Serine/Threonine Protein Kinase B Raf Inhibitor, Lymphocyte Activation Gene 3 Protein Inhibitor, Dual Specificity Mitogen Activated Protein Kinase Kinase 1 Inhibitor, Tumor Necrosis Factor Receptor Superfamily Member 9 Agonist, Vascular Endothelial Growth Factor Receptor 2 Inhibitor, Tumor Necrosis Factor Receptor Superfamily Member 5 Agonist, and CD3 Agonist, among others.
-
What are the key routes of administration in the Melanoma pipeline products market?
The key routes of administration in the Melanoma pipeline products market are intravenous, oral, intratumor, subcutaneous, parenteral, intravenous drip, intradermal, intramuscular, intraperitoneal, and intralesional, among others.
-
What are the key molecule types in the Melanoma pipeline products market?
The key molecule types in the Melanoma pipeline products market are small molecule, monoclonal antibody, cell therapy, fusion protein, gene-modified cell therapy, oncolytic virus, subunit vaccine, biologic, and monoclonal antibody conjugated, among others.
-
Which are the leading companies in the Melanoma pipeline products market?
Some of the leading companies in the Melanoma pipeline products market are Bristol-Myers Squibb Co, F. Hoffmann-La Roche Ltd, Merck & Co Inc, Novartis AG, Pfizer Inc, AstraZeneca Plc, Regeneron Pharmaceuticals Inc, Boehringer Ingelheim International GmbH, Eisai Co Ltd, and Incyte Corp.
Get in touch to find out about multi-purchase discounts
reportstore@globaldata.com
Tel +44 20 7947 2745
Every customer’s requirement is unique. With over 220,000 construction projects tracked, we can create a tailored dataset for you based on the types of projects you are looking for. Please get in touch with your specific requirements and we can send you a quote.
Related reports
View more Oncology reports